NDC 29300-207 – pramipexole dihydrochloride
Pramipexole Dihydrochloride .125 mg/1 · Tablet · Oral
Product NDC29300-207
Product details
- Brand name
- pramipexole dihydrochloride
- Generic name
- pramipexole dihydrochloride
- Labeler
- Unichem Pharmaceuticals (USA), Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA207011
- Marketed since
- March 1, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nonergot Dopamine Agonist
Active ingredients
- Pramipexole Dihydrochloride .125 mg/1
Uses, dosage, side effects and warnings for pramipexole dihydrochloride →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 29300-207-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (29300-207-10) | Mar 1, 2019 |
| 29300-207-16 | 60 TABLET in 1 BOTTLE, PLASTIC (29300-207-16) | Mar 1, 2019 |
| 29300-207-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-207-19) | Mar 1, 2019 |
Other pramipexole dihydrochloride products
- 50090-7816 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 50090-2455 Pramipexole Dihydrochloride .5 mg/1 · Tablet · A-S Medication Solutions
- 50090-3280 Pramipexole Dihydrochloride .25 mg/1 · Tablet · A-S Medication Solutions
- 50090-5036 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · A-S Medication Solutions
- 62332-003 Pramipexole Dihydrochloride .125 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-156 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-005 Pramipexole Dihydrochloride .5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-007 Pramipexole Dihydrochloride 1.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-006 Pramipexole Dihydrochloride 1 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-155 Pramipexole Dihydrochloride .75 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-004 Pramipexole Dihydrochloride .25 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-154 Pramipexole Dihydrochloride .375 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.